WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer.

Flore-Anne PoujadeAarren MannionNicholas BrittainAndrew TheodosiEllie BeebyKatarzyna B LeszczynskaEster M HammondJohn GreenmanChristopher CawthorneIsabel M Pires

Published in: British journal of cancer (2018)

Our data suggests that WSB-1 may be an important regulator of aggressive metastatic disease in hormone receptor-negative breast cancer. WSB-1 could therefore represent a novel regulator and therapeutic target for secondary breast cancer in these patients.

Keyphrases

end stage renal disease
small cell lung cancer
squamous cell carcinoma
newly diagnosed
chronic kidney disease
transcription factor
peritoneal dialysis
prognostic factors
patient reported outcomes
deep learning
childhood cancer